175 related articles for article (PubMed ID: 36348031)
1. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
[TBL] [Abstract][Full Text] [Related]
2. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
[TBL] [Abstract][Full Text] [Related]
3. SDH-B, INSM1, and GATA3 expression in cauda equina neuroendocrine tumors: report on 21 cases from a North indian tertiary care center.
Sood R; Chatterjee D; Bhardwaj S; Singla N; Ahuja C; Radotra B
Hum Pathol; 2023 Jul; 137():18-24. PubMed ID: 37100233
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Suwala A; Stichel D; Wefers AK; Wessels L; Misch M; Kim HY; Jödicke R; Teichmann D; Kaul D; Kahn J; Bockmayr M; Hasselblatt M; Younsi A; Unterberg A; Knie B; Walter J; Al Safatli D; May SA; Jödicke A; Ntoulias G; Moskopp D; Vajkoczy P; Heppner FL; Capper D; Hartmann W; Hartmann C; von Deimling A; Reuss DE; Schöler A; Koch A
Acta Neuropathol; 2020 Dec; 140(6):893-906. PubMed ID: 32926213
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
[TBL] [Abstract][Full Text] [Related]
6. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
[TBL] [Abstract][Full Text] [Related]
7. Cauda equina neuroendocrine tumor: a report of three cases and review of the literature with focus on differential diagnosis and postoperative management.
Fabbrocini L; Zin F; Keyvani K; Ebner FH
Neurosurg Rev; 2024 Apr; 47(1):166. PubMed ID: 38632184
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
Ramani B; Gupta R; Wu J; Barreto J; Bollen AW; Tihan T; Mummaneni PV; Ames C; Clark A; Oberheim Bush NA; Butowski N; Phillips D; King BE; Bator SM; Treynor EC; Zherebitskiy V; Quinn PS; Walker JB; Pekmezci M; Sullivan DV; Hofmann JW; Sloan EA; M Chang S; Berger MS; Solomon DA; Perry A
Acta Neuropathol; 2020 Dec; 140(6):907-917. PubMed ID: 32892244
[TBL] [Abstract][Full Text] [Related]
9. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
10. Locally invasive giant spinal paraganglioma.
Yi Chen B; Jose Mizrahi C; Yang Y; Kavar B
J Clin Neurosci; 2020 Aug; 78():430-432. PubMed ID: 32334958
[TBL] [Abstract][Full Text] [Related]
11. Paraganglioma of the cauda equina: A clinicopathologic study of 12 cases with demonstration of cytokeratin positivity.
Zhang Y; Du Z; Xiong J; Wang Y; Yin B
Ann Diagn Pathol; 2022 Apr; 57():151887. PubMed ID: 35033938
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
13. Paraganglioma of the cauda equina region.
Corinaldesi R; Novegno F; Giovenali P; Lunardi T; Floris R; Lunardi P
Spine J; 2015 Mar; 15(3):e1-8. PubMed ID: 25452014
[TBL] [Abstract][Full Text] [Related]
14. Cauda equina neuroendocrine tumors: A single institutional imaging review of cases over two decades.
Ajmera P; Agarwal AK; Mehta PM; Benson JC; Madhavan AA; Diehn FE; Soni N; Bathla G
Neuroradiol J; 2024 Feb; 37(1):84-91. PubMed ID: 37933451
[TBL] [Abstract][Full Text] [Related]
15. Paraganglioma of the cauda equina. A case report and review of the literature.
Bak J; Olsson Y; Grimelius L; Spännare B
APMIS; 1996 Mar; 104(3):234-40. PubMed ID: 8611199
[TBL] [Abstract][Full Text] [Related]
16. [Paraganglioma of the cauda equina region: Report of 9 cases].
Seidou F; Tamarit C; Sevestre H
Ann Pathol; 2020 Nov; 40(6):436-441. PubMed ID: 32331813
[TBL] [Abstract][Full Text] [Related]
17. Paragangliomas in the cauda equina region: clinicopathoradiologic findings in four cases.
Yang SY; Jin YJ; Park SH; Jahng TA; Kim HJ; Chung CK
J Neurooncol; 2005 Mar; 72(1):49-55. PubMed ID: 15803375
[TBL] [Abstract][Full Text] [Related]
18. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
[TBL] [Abstract][Full Text] [Related]
19. Primary Paraganglioma of the Spine: A Systematic Review of Clinical Features and Surgical Management in Cauda Equina versus Non-Cauda Equina Lesions.
Palmisciano P; Sagoo NS; Haider AS; Ogasawara C; Ogasawara M; Bin Alamer O; Heidari KS; Raj KM; Scalia G; Umana GE; Krishnaney AA; Aoun SG; Passias PG; Vira S
World Neurosurg; 2022 May; 161():190-197.e20. PubMed ID: 35123022
[TBL] [Abstract][Full Text] [Related]
20. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
